Old Lyme, CT, United States of America

Susan Faas McKnight

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 70(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Susan Faas McKnight

Introduction: Susan Faas McKnight is a prominent inventor based in Old Lyme, Connecticut, whose work has significantly impacted the field of immunology. With a remarkable portfolio of eight patents, she has dedicated her career to developing innovative methods and compositions that enhance immune responses and transplant success.

Latest Patents: Among her latest patents are two critical disclosures that focus on antibodies to OX-2/CD200 and their applications in medical therapies. The first patent outlines methods and compositions for inhibiting immune responses, particularly aimed at preventing graft rejection and improving graft survival. This work provides a foundation for more effective transplant procedures, potentially revolutionizing patient outcomes. The second patent elaborates on the use of an anti-CD200 antibody for prolonging the survival of allografts, detailing the mechanisms through which these antibodies can be used to enhance the longevity of transplanted organs in mammalian recipients. These patents additionally introduce biomarkers to assess the efficacy of the immunomodulatory effects induced by anti-CD200 antibodies, along with related pharmaceutical compositions, kits, and solutions.

Career Highlights: Susan is currently employed at Alexion Pharmaceuticals, Inc., where she utilizes her expertise to pioneer advancements in therapeutic interventions. Her contributions to the scientific community are underscored by her continuous efforts to bridge the gap between research and clinical applications.

Collaborations: Throughout her career, Susan has collaborated with notable colleagues, including Katherine S. Bowdish and Anke Kretz-Rommel. These partnerships enhance the scope of innovation through shared knowledge and interdisciplinary approaches, contributing to the success of their collective endeavors in immunology and therapeutics.

Conclusion: Susan Faas McKnight embodies the spirit of innovation, consistently pushing the boundaries of what is possible in medical science. Her patents reflect a commitment to improving patient care and advancing our understanding of immune responses. As she continues her work at Alexion Pharmaceuticals, her contributions are sure to shape the future of medical treatments and inspire the next generation of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…